Clinical Trial Update: SpecTRA; A Study of the Validation of Protein Biomarkers in Transient Ischemic Attack

View source ↗

Summary

The SpecTRA trial, which validates protein biomarkers for transient ischemic attack, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Ischemic Attack

Snippet

Sponsor: Andrew Penn | Conditions: TIA | Status: COMPLETED